Minireviews
Copyright ©The Author(s) 2023. Published by Baishideng Publishing Group Inc. All rights reserved.
World J Virol. Jan 25, 2023; 12(1): 1-11
Published online Jan 25, 2023. doi: 10.5501/wjv.v12.i1.1
Joint replacement and human immunodeficiency virus
Maryam Salimi, Peyman Mirghaderi, Seyedarad Mosalamiaghili, Ali Mohammadi, Amirhossein Salimi
Maryam Salimi, Department of Orthopedic Surgery, Shiraz University of Medical Sciences, Shiraz 71936-13311, Iran
Peyman Mirghaderi, Students' Scientific Research Center, Tehran University of Medical Sciences, Tehran 7138433608, Iran
Seyedarad Mosalamiaghili, Ali Mohammadi, Student Research Committee, Shiraz University of Medical Sciences, Shiraz 7136587666, Iran
Amirhossein Salimi, Department of Medicine, Shahid Sadoughi University of Medical Sciences, Yazd 7156893040, Iran
Author contributions: Salimi M performed the idea and revised the manuscript significantly; Mohammadi A drafted the manuscript; Mirghaderi P prepared the figures; Mosalamiaghili S revised the manuscript; Salimi A performed the literature review.
Conflict-of-interest statement: There is no conflict of interest associated with any of the senior authors or other coauthors who contributed their efforts to this manuscript.
Open-Access: This article is an open-access article that was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution NonCommercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: https://creativecommons.org/Licenses/by-nc/4.0/
Corresponding author: Maryam Salimi, MD, Research Assistant, Department of Orthopedic Surgery, Shiraz University of Medical Sciences, Zand Avevue, Shiraz 71936-13311, Iran. salimimaryam7496@gmail.com
Received: July 26, 2022
Peer-review started: July 26, 2022
First decision: October 21, 2022
Revised: November 19, 2022
Accepted: December 8, 2022
Article in press: December 8, 2022
Published online: January 25, 2023
Core Tip

Core Tip: The outcome and prevalence of complications are controversial among human immunodeficiency virus-infected cases who need arthroplasty. According to our literature review, total joint replacement procedures are recommended based on patient-specific factors such as viral load, CD4+ T-cell count, clinical classification, history of intravenous drug addiction, and the patient's overall health. Optimization with antiviral drugs is also suggested before elective arthroplasty.